drugset / Trial / NCT03662893

Behavioural Therapy With Checklist for Overactive Bladder

NCT03662893

RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this study is to investigate the efficiency of this newly-established checklist for overactive bladder (OAB) and whether determinate to adherence and persistence rate of combination of behavioural therapy and anticholinergic medications in patients with OAB.

Timeline

Start
2015-01-01
Primary completion
2017-12-31
Completion
2018-04-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Darifenacin Small molecule
Comparator Fesoterodine Other / unclassified
Comparator Propiverine Small molecule
Comparator Solifenacin Small molecule
Comparator Tolterodine Small molecule

Indications